表紙
市場調査レポート

サイトメガロウイルス網膜炎:世界の治験レビュー

Cytomegalovirus (CMV) Retinitis Global Clinical Trials Review, H2, 2014

発行 GlobalData 商品コード 319596
出版日 ページ情報 英文 66 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.39円で換算しております。
Back to Top
サイトメガロウイルス網膜炎:世界の治験レビュー Cytomegalovirus (CMV) Retinitis Global Clinical Trials Review, H2, 2014
出版日: 2014年11月17日 ページ情報: 英文 66 Pages
概要

当レポートでは、サイトメガロウイルス網膜炎の臨床試験に関連する基本情報やデータを提供しており、試験件数および被験者の募集状況、段階別の動向、臨床試験を実施している主な製薬企業および研究機関のプロファイルなどをまとめています。

イントロダクション

  • サイトメガロウイルス網膜炎
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • 欧州の主要国における治験件数
    • 北米の主要国における治験件数

G7諸国での治験件数:感染症治療薬の治験におけるサイトメガロウイルス網膜炎の割合

G7諸国における段階別の治験件数

G7諸国での治験件数:進捗状況別

段階別の治験件数

進捗状況別の治験件数

治験の目標の達成状況

未完了の治験件数

スポンサーの種類別の治験件数

有望なスポンサー

サイトメガロウイルス網膜炎治療薬の治験に携わっている主要企業

有望な薬剤

治験のプロファイル

  • 主要企業の治験の概要
    • F. Hoffmann-La Roche Ltd.
    • Novartis AG
    • Isis Pharmaceuticals, Inc.
    • AstraZeneca PLC
    • Gilead Sciences, Inc.
    • Roche Global Development
    • Pfizer Inc.
    • Merck & Co., Inc.
    • Astra AB
  • 代表的な研究機関・病院の治験の概要
    • The National Institute of Allergy and Infectious Diseases
    • National Eye Institute
    • The American National Red Cross
    • Medical University of Vienna
    • University Hospital Basel
    • National Center for Research Resources
    • National Cancer Institute
    • National Heart, Lung, and Blood Institute

5つの代表的な治験のプロファイル

付録

目次
Product Code: GDHC2427CTIDB

GlobalData's clinical trial report, "Cytomegalovirus (CMV) Retinitis Global Clinical Trials Review, H2, 2014" provides data on the Cytomegalovirus (CMV) Retinitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cytomegalovirus (CMV) Retinitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cytomegalovirus (CMV) Retinitis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Cytomegalovirus (CMV) Retinitis
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
  • Clinical Trials by G7 Countries: Proportion of Cytomegalovirus (CMV) Retinitis to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Cytomegalovirus (CMV) Retinitis
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Isis Pharmaceuticals, Inc.
      • Clinical Trial Overview of Isis Pharmaceuticals, Inc.
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
      • Gilead Sciences, Inc.
      • Clinical Trial Overview of Gilead Sciences, Inc.
      • Roche Global Development
      • Clinical Trial Overview of Roche Global Development
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • Astra AB
      • Clinical Trial Overview of Astra AB
    • Clinical Trial Overview of Top Institutes / Government
      • The National Institute of Allergy and Infectious Diseases
      • Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases
      • National Eye Institute
      • Clinical Trial Overview of National Eye Institute
      • The American National Red Cross
      • Clinical Trial Overview of The American National Red Cross
      • Medical University of Vienna
      • Clinical Trial Overview of Medical University of Vienna
      • University Hospital Basel
      • Clinical Trial Overview of University Hospital Basel
      • National Center for Research Resources
      • Clinical Trial Overview of National Center for Research Resources
      • National Cancer Institute
      • Clinical Trial Overview of National Cancer Institute
      • National Heart, Lung, and Blood Institute
      • Clinical Trial Overview of National Heart, Lung, and Blood Institute
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Cytomegalovirus (CMV) Retinitis Therapeutics, Global, Clinical Trials by Region, 2014*
  • Cytomegalovirus (CMV) Retinitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials, Europe, Top Countries, 2014*
  • Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Proportion of Cytomegalovirus (CMV) Retinitis to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • Cytomegalovirus (CMV) Retinitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Cytomegalovirus (CMV) Retinitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Cytomegalovirus (CMV) Retinitis Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Cytomegalovirus (CMV) Retinitis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Cytomegalovirus (CMV) Retinitis Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Cytomegalovirus (CMV) Retinitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014*
  • Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014*
  • Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Isis Pharmaceuticals, Inc., 2014*
  • Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014*
  • Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2014*
  • Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Roche Global Development, 2014*
  • Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014*
  • Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Astra AB, 2014*
  • Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014*
  • Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Eye Institute, 2014*
  • Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by The American National Red Cross, 2014*
  • Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2014*
  • Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Basel, 2014*
  • Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Center for Research Resources, 2014*
  • Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014*
  • Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014*

List of Figures

  • Cytomegalovirus (CMV) Retinitis Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Cytomegalovirus (CMV) Retinitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials, Europe, Top Countries (%), 2014*
  • Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Proportion of Cytomegalovirus (CMV) Retinitis to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • Cytomegalovirus (CMV) Retinitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Cytomegalovirus (CMV) Retinitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Cytomegalovirus (CMV) Retinitis Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Cytomegalovirus (CMV) Retinitis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Cytomegalovirus (CMV) Retinitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • GlobalData Methodology
Back to Top